TY - JOUR
T1 - Severe inhibitor-negative acquired factor XIII/13 deficiency with aggressive subdural haemorrhage
AU - Kawano, Hiroki
AU - Yamamoto, Daisuke
AU - Uchihashi, Yoshito
AU - Wakahashi, Kanako
AU - Kawano, Yuko
AU - Sada, Akiko
AU - Minagawa, Kentaro
AU - Katayama, Yoshio
AU - Kohmura, Eiji
AU - Souri, Masayoshi
AU - Ichinose, Akitada
PY - 2013/9
Y1 - 2013/9
N2 - Acquired factor XIII (FXIII) deficiency is a common disease and seldom causes bleeding. However, severe FXIII deficiency may result in life-threatening bleeding. Although the inhibitor against FXIII has recently been focused as the cause of haemorrhagic acquired FXIII deficiency, the pathophysiology of inhibitor-negative cases could also be involved. We report a case of an 85-year-old Japanese man with serious subdural haemorrhage showing a remarkable decreased level of FXIII activity. He also manifested complications of compensated disseminated intravascular coagulation (DIC) with chronic renal failure, abdominal aortic aneurysm (AAA) and right renal carcinoma. Despite the successful evacuation of the haemorrhage, acute subdural haemorrhage subsequently developed that necessitated further craniotomies. Plasma cross-mixing studies and dot blot assay revealed no inhibitors against FXIII. We speculated that the decreased FXIII activity could be mainly due to hyperconsumption by DIC and surgery. Because plasma-derived FXIII concentrates are available to stop bleeding, clinicians should be aware of severe acquired inhibitor-negative FXIII deficiency in cases of unexplained excessive bleeding.
AB - Acquired factor XIII (FXIII) deficiency is a common disease and seldom causes bleeding. However, severe FXIII deficiency may result in life-threatening bleeding. Although the inhibitor against FXIII has recently been focused as the cause of haemorrhagic acquired FXIII deficiency, the pathophysiology of inhibitor-negative cases could also be involved. We report a case of an 85-year-old Japanese man with serious subdural haemorrhage showing a remarkable decreased level of FXIII activity. He also manifested complications of compensated disseminated intravascular coagulation (DIC) with chronic renal failure, abdominal aortic aneurysm (AAA) and right renal carcinoma. Despite the successful evacuation of the haemorrhage, acute subdural haemorrhage subsequently developed that necessitated further craniotomies. Plasma cross-mixing studies and dot blot assay revealed no inhibitors against FXIII. We speculated that the decreased FXIII activity could be mainly due to hyperconsumption by DIC and surgery. Because plasma-derived FXIII concentrates are available to stop bleeding, clinicians should be aware of severe acquired inhibitor-negative FXIII deficiency in cases of unexplained excessive bleeding.
UR - http://www.scopus.com/inward/record.url?scp=84882456645&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84882456645&partnerID=8YFLogxK
U2 - 10.1097/MBC.0b013e32835facef
DO - 10.1097/MBC.0b013e32835facef
M3 - Article
C2 - 23511901
AN - SCOPUS:84882456645
SN - 0957-5235
VL - 24
SP - 638
EP - 641
JO - Blood Coagulation and Fibrinolysis
JF - Blood Coagulation and Fibrinolysis
IS - 6
ER -